Survival Rate and Predictors of Mortality Among TB-HIV Co-Infected Patients During Tuberculosis Treatment at Public Health Facilities in Bahir Dar City, Northwest Ethiopia
Teshager Worku Kegne,Zelalem Alamrew Anteneh,Tadios Lidetu Bayeh,Birhanu Melaku Shiferaw,Desiyalew Habtamu Tamiru
DOI: https://doi.org/10.2147/idr.s446020
2024-04-09
Infection and Drug Resistance
Abstract:Teshager Worku Kegne, 1, &ast Zelalem Alamrew Anteneh, 2, &ast Tadios Lidetu Bayeh, 2, &ast Birhanu Melaku Shiferaw, 3, &ast Desiyalew Habtamu Tamiru 4, &ast 1 Department of Health Services, Management Sciences for Health, Addis Ababa, Ethiopia; 2 Department of Epidemiology and Biostatistics, School of Public Health, Bahir Dar University, Bahir Dar, Ethiopia; 3 Department of Public Health, Gamby Medical and Business College, Bahir Dar, Ethiopia; 4 Department of Public Health Emergency, Humedica e.V International Aid Organization, Addis Ababa, Ethiopia &astThese authors contributed equally to this work Correspondence: Desiyalew Habtamu Tamiru, Tel +251912717030, Email Background: Tuberculosis and human immunodeficiency virus co-infection pose a major public health concern, particularly in developing countries. The survival and predictors of mortality were not sufficiently studied among TB-HIV co-infected patients in Ethiopia. Objective: This study aimed to investigate the survival rate and predictors of mortality among TB-HIV co-infected patients during TB treatment at public health facilities in Bahir Dar, Northwest Ethiopia. Methods: A retrospective follow-up study was conducted among 401 TB-HIV co-infected patients who were treated for tuberculosis between July 2018 and June 2022 at public health facilities in Bahir Dar city, Ethiopia. Data were collected using a structured checklist from patient charts. Data entry and analysis were done using EpiData 3.1 and Stata version 15, respectively. A Cox proportional Hazard regression model was used to identify predictors of mortality. Predictors with P < 0.05 in the multivariable regression were considered statistically significant. Results: Among the 401 TB-HIV co-infected patients, 59 (14.7%) died during the follow-up period. Predictors like lower BMI (AHR = 3.00, 95% CI = 1.44, 6.28), extrapulmonary TB infection (AHR = 3.30, 95% CI = 1.50, 7.29), presence of opportunistic infection (AHR = 5.07, 95% CI = 2.55, 10.08), functional status (bedridden: AHR = 4.49, 95% CI = 1.63, 12.33), and adherence to TB treatment (fair = AHR = 2.74, 95% CI = 1.41, 7.20, and poor = AHR = 3.75, 95% CI = 1.52, 9.23) were associated with mortality. Conclusion: Mortality among TB and HIV coinfected people was high at public health facilities in Bahir Dar city. This result suggested that in order to increase patient survival, it would be necessary to enhance nutritional status, increase adherence to TB treatment, and prevent opportunistic infections. Keywords: TB, HIV, mortality, predictors, retrospective, survival, Ethiopia Tuberculosis (TB) and the Human Immunodeficiency Virus (HIV) are among the leading public health problems globally. Tuberculosis is one of the most common illnesses and causes of death among people living with HIV (PLWHIV). HIV positive individuals have a 20–30 times greater risk of contracting TB than HIV negative individuals due to lowered immunity. Reports also indicated that PLWHIV are more likely to develop active TB than HIV negative. 1,2 The global TB report 2021 stated that out of ten million people infected with TB, 8% were PLHIV. The proportion of TB episodes coinfected with HIV was highest in the African region, exceeding 50% in parts of Southern Africa. 2 TB and HIV form a lethal combination, each speeding the other's progress. As a result, individuals with co-infections of TB and HIV have a significant risk of increased mortality. Without proper treatment, 60% of HIV-negative people with TB on average and nearly all HIV-positive people with TB will die. 3 Globally, 1.6 million people died from TB and 1 million from HIV in 2017 and accounting for one in every 300,000 deaths from both diseases. 1 Most recently, about one-third of all AIDS-related deaths worldwide are caused by TB, which is the leading cause of death among HIV-positive individuals. An estimated 167,000 people died from TB-HIV coinfection in 2022. 3 The syndromic interaction between TB and HIV has played a ruinous role, with Africans bearing a disproportionate share of the burden. In 2019, people in Africa accounted for 73% of TB-HIV co-infection cases and 81% of all TB-HIV deaths. At the country level, South Africa and Nigeria rank among the worst affected in sub-Saharan Africa and globally for both diseases. 4,5 In addition to TB disease, PLHIV bears a high burden of drug-resistant TB strains; thus, if diagnosis is delayed, there is an increased risk of mortality from multidrug-resistant and extensively drug-resistant TB in this population. 6</ -Abstract Truncated-
pharmacology & pharmacy,infectious diseases